INNOVEL

INNOVEL Intelligent Technology is a leading provider of intelligent R&D and production solutions for the life sciences and biopharmaceutical industries. Headquartered in Suzhou, China, with a significant presence in Boston and Shanghai, the company specializes in automating complex laboratory and manufacturing processes for a variety of modalities, including antibodies, cell and gene therapies (CGT), and nucleic acids. Its flagship platforms, such as INNOSMART and CELLFAC, integrate advanced robotics, AI-driven algorithms, and GMP-compliant hardware to enhance efficiency, scalability, and quality consistency from drug discovery to commercial production. Backed by strategic investment from WuXi Biologics, INNOVEL serves a global clientele of pharmaceutical companies, CROs, and research institutions, positioning itself as a critical infrastructure partner in the digital transformation of biotechnology.